(NASDAQ: MLEC) Moolec Science Sa's forecast annual revenue growth rate of 158.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and it is also forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Moolec Science Sa's revenue in 2025 is $7,832,927.On average, 3 Wall Street analysts forecast MLEC's revenue for 2026 to be $35,227,232, with the lowest MLEC revenue forecast at $33,843,105, and the highest MLEC revenue forecast at $36,263,327. On average, 3 Wall Street analysts forecast MLEC's revenue for 2027 to be $315,536,948, with the lowest MLEC revenue forecast at $303,159,812, and the highest MLEC revenue forecast at $324,817,799.
In 2028, MLEC is forecast to generate $533,608,954 in revenue, with the lowest revenue forecast at $512,647,031 and the highest revenue forecast at $549,290,393.